Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients with liver metastases. The results showed that Chemosaturation-Percutaneous Hepatic Perfusion (CS-PHP) had significantly longer overall survival (516 days) compared to Transarterial Radioembolization (SIRT) (300.5 days).

mint Lesion™ was used to assess the treatment efficacy in line with the Response Evaluation Criteria in Solid Tumors (RECIST 1.1). The study observed that the disease control rate, which includes Complete Response (CR), Partial Response (PR), and Stable Disease (SD), was 18% for SIRT and 30% for CS-PHP.

These findings highlight the need for further research and prospective randomized trials to optimize liver-targeted treatment strategies and address the challenges faced by patients with this condition. Learn more.

Clinical Trials Clinical Routine Standardized Reading Procedures Therapy Response Assessment Data Collection RECIST Research with mint

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™ on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

A picture of radiologists looking at a screen showing the restaging of the HNSCC

Study Highlights the Potential of Radiomics in Medical Intervention

A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy…